Adaptimmune Therapeutics plc
ADAP
$0.0569
-$0.0016-2.74%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -56.25% | -60.71% | -18.53% | -13.36% | 49.52% |
Total Receivables | 38.57% | 30.47% | -58.61% | 62.48% | -17.75% |
Inventory | -2.96% | 59.36% | 274.38% | 54.23% | -23.38% |
Prepaid Expenses | 10.13% | -25.50% | -29.17% | 32.98% | 8.09% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 4.99% | 5.65% | -6.07% | 2.68% | 15.86% |
Total Current Assets | -24.16% | -45.26% | -22.95% | -3.77% | 35.78% |
|
|||||
Total Current Assets | -24.16% | -45.26% | -22.95% | -3.77% | 35.78% |
Net Property, Plant & Equipment | -4.17% | -4.45% | -21.55% | 1.90% | -5.40% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.03% | -1.91% | -9.41% | 330.02% | 90.08% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -22.17% | -13.69% | -26.12% | 27.32% | 0.28% |
Total Assets | -17.36% | -35.73% | -22.52% | -1.33% | 24.69% |
|
|||||
Total Accounts Payable | 65.20% | -34.41% | -4.16% | 20.71% | 14.06% |
Total Accrued Expenses | 1.45% | -28.10% | 1.85% | -1.32% | 37.18% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -2.44% | -1.74% | 12.79% | -21.12% | 0.82% |
Total Finance Division Other Current Liabilities | -18.81% | -8.39% | 1.77% | -48.41% | 19.77% |
Total Other Current Liabilities | -18.81% | -8.39% | 1.77% | -48.41% | 19.77% |
Total Current Liabilities | 0.86% | -20.85% | 1.69% | -22.68% | 23.58% |
|
|||||
Total Current Liabilities | 0.86% | -20.85% | 1.69% | -22.68% | 23.58% |
Long-Term Debt | 1.04% | -49.42% | 0.75% | 99.83% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -0.95% | -3.09% | -5.83% | 19.61% | -7.27% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.54% | 0.26% | -3.46% | 2.34% | -31.91% |
Total Liabilities | 3.12% | -16.49% | -1.40% | 5.33% | -3.51% |
|
|||||
Common Stock & APIC | 0.27% | 0.07% | 0.26% | 0.28% | 0.28% |
Retained Earnings | -2.66% | -4.35% | -7.28% | -1.76% | 6.49% |
Treasury Stock & Other | -140.53% | -131.97% | 62.97% | -50.53% | -25.44% |
Total Common Equity | -89.58% | -415.88% | -85.19% | -16.92% | 294.97% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -89.58% | -415.88% | -85.19% | -16.92% | 294.97% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -89.58% | -415.88% | -85.19% | -16.92% | 294.97% |
|